Protagen AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Protagen AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014281
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The company’s products include multilisa Ssc, multilisa SLE and multilisa RA. It provides products for autoimmune diseases such as rheumatoid arthritis, neuromyelitis optica, systemic lupus erythematosus, systemic sclerosis, multiple sclerosis and ankylosing spondylitis. Protagen’s technology comprise SeroTag, which enables differential diagnosis and patient stratification in various diseases. The company also develops companion diagnostics to pharmaceutical and biotechnology companies. The company partners with various educational organization and other healthcare companies. It markets its products through its network of distributors. Protagen is headquartered in Dortmund, Germany.

Protagen AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Protagen AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Protagen AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Protagen AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Protagen AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Protagen AG, Medical Devices Deals, 2011 to YTD 2017 9
Protagen AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Protagen AG, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Protagen Raises USD12.5 Million in Venture Financing 11
Partnerships 12
National Center for Tumor Diseases Heidelberg Enters into Agreement wtih Protagen 12
Protagen Enters into Agreement with Novartis Pharma 13
Protagen Enters into Co-Development Agreement with Mikrogen 14
Protagen Enters into Agreement with Qiagen to Develop Novel Protein-Based Companion Diagnostics 15
Protagen Enters Into Biomarker Discovery Agreement With Pfizer 16
Protagen Enters Into Co-Marketing Agreement With Charles River Labs 17
instrAction Enters Into An Agreement With Protagen 18
Acquisition 19
Zukunftsfonds Heilbronn Acquires Protagen Protein Services From Protagen 19
Protagen AG – Key Competitors 20
Protagen AG – Key Employees 21
Protagen AG – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Corporate Communications 23
Jul 20, 2016: Protagen Appoints Bernhard Kirschbaum as New Chairman and Oliver Schacht as New Board Member 23
Other Significant Developments 24
Jan 21, 2016: Protagen AG Joins RA-MAP Consortium to Support Identification of Predictors of Remission in Rheumatoid Arthritis 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Protagen AG, Pharmaceuticals & Healthcare, Key Facts 2
Protagen AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Protagen AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Protagen AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Protagen AG, Deals By Therapy Area, 2011 to YTD 2017 8
Protagen AG, Medical Devices Deals, 2011 to YTD 2017 9
Protagen AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Protagen Raises USD12.5 Million in Venture Financing 11
National Center for Tumor Diseases Heidelberg Enters into Agreement wtih Protagen 12
Protagen Enters into Agreement with Novartis Pharma 13
Protagen Enters into Co-Development Agreement with Mikrogen 14
Protagen Enters into Agreement with Qiagen to Develop Novel Protein-Based Companion Diagnostics 15
Protagen Enters Into Biomarker Discovery Agreement With Pfizer 16
Protagen Enters Into Co-Marketing Agreement With Charles River Labs 17
instrAction Enters Into An Agreement With Protagen 18
Zukunftsfonds Heilbronn Acquires Protagen Protein Services From Protagen 19
Protagen AG, Key Competitors 20
Protagen AG, Key Employees 21

★海外企業調査レポート[Protagen AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Petro Matad Ltd (MATD):企業の財務・戦略的SWOT分析
    Summary Petro Matad Ltd (Petro Matad) is an oil and gas company that develops and operates oil and gas exploration properties. The company’s upstream oil and gas exploration asset base includes Block IV, Block XX, and Block V. Its Block XX is located in the far eastern part of Mongolia producing oil …
  • Regenera Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Regenera Pharma Ltd (Regenera Pharma) is a pharmaceutical company that develops a novel drug for neurological indications. The company provides product RPh201, which is a botanical drug developed to repair permanent damages caused by neurological diseases that afflict the central nervous sys …
  • Cell C (Pty) Ltd.:企業の戦略・SWOT・財務情報
    Cell C (Pty) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Cell C (Pty) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Canadian Utilities Ltd (CU):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Utilities Ltd (CUL), an ATCO company, is an electric utility. The company carries out electricity and natural gas distribution and transmission operations. It constructs and maintains electrical transmission and distribution lines and has stakes in generating plants through subsidia …
  • Copperbelt Energy Corporation PLC (CEC)-エネルギー分野:企業M&A・提携分析
    Summary Copperbelt Energy Corporation PLC (CEC) is an electric utility that generates, transmits, distributes and sells energy. The company generates electricity from hydro, solar, gas and thermal sources; transmits electricity through a network of transmission lines and high voltage substations and …
  • NeuroDerm Ltd:医療機器:M&Aディール及び事業提携情報
    Summary NeuroDerm Ltd (NeuroDerm), a subsidiary of Mitsubishi Tanabe Pharma Corp, is a pharmaceutical company that develops of drugs for the treatment of Parkinson’s disease and central nervous system (CNS) disorders through proprietary reformulations of its existing drugs. The company’s liquid form …
  • Harbin Electric International Co Ltd:企業の戦略的SWOT分析
    Harbin Electric International Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Par Pacific Holdings Inc (PARR):石油・ガス:M&Aディール及び事業提携情報
    Summary Par Pacific Holdings Inc (Par Pacific), formerly known as Par Petroleum Corporation, manages, owns and maintains interests in energy and infrastructure related businesses. It has operations across the value chain from natural gas production to distribution and transportation. The company con …
  • F-Secure Oyj (FSC1V):企業の財務・戦略的SWOT分析
    F-Secure Oyj (FSC1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Morinaga & Co. Ltd.:企業の戦略・SWOT・財務情報
    Morinaga & Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Morinaga & Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • eFFECTOR Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary eFFECTOR Therapeutics Inc (eFFECTOR) is a clinical-stage biopharmaceutical company that focuses on the discovery and development of selective translation regulators for the treatment of cancer. Its investigational compounds are designed to restore the translational control of processes that …
  • Intech Biopharm Ltd (6461):製薬・医療:M&Aディール及び事業提携情報
    Summary Intech Biopharm Ltd (Intech Biopharm) is a drug developing company that develops drugs for obstructive airway diseases. The company provides marketed products such as single ingredient generics such as Synvent, and Duasma, developed for asthma; and multi-ingredient generic, Synflutide, for a …
  • KACO new energy GmbH:企業の戦略的SWOT分析
    KACO new energy GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • The Lubrizol Corp:企業の戦略的SWOT分析
    The Lubrizol Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Tgb Banquets And Hotels
    Tgb Banquets And Hotels - Strategy, SWOT and Corporate Finance Report Summary Tgb Banquets And Hotels - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Gastar Exploration Inc (GST):石油・ガス:M&Aディール及び事業提携情報
    Summary Gastar Exploration Inc (Gastar), formerly Gastar Exploration Ltd, is an energy company that offers exploration and development programs. The company explores, develops and produces natural gas, oil, and natural gas liquids. Its business activities include acquisition, identification, and exp …
  • CUNA Mutual Group:企業の戦略・SWOT・財務情報
    CUNA Mutual Group - Strategy, SWOT and Corporate Finance Report Summary CUNA Mutual Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Mizuho Trust & Banking Co Ltd:企業の戦略・SWOT・財務情報
    Mizuho Trust & Banking Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Mizuho Trust & Banking Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Cummins Inc (CMI):企業の財務・戦略的SWOT分析
    Cummins Inc (CMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Mitsubishi Estate Co., Ltd.:企業の戦略・SWOT・財務分析
    Mitsubishi Estate Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Estate Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆